FDA’s preliminary findings have raised concerns about a lack of sterility assurance for products produced at and distributed by this facility.
This is a summary of an alert issued by MedWatch: The FDA Safety Information and Adverse Event Reporting Program. The link below will take you to the original notice.
View Full Details Of The Original MedWatch Notice Here.
